These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

712 related items for PubMed ID: 9892211

  • 21. Intercellular heterogeneity of early mitogenic events: cAMP generalizes the EGF effect on c-Fos protein appearance but not on MAP kinase phosphorylation and nuclear translocation in dog thyroid epithelial cells.
    Baptist M, Dumont JE, Roger PP.
    Exp Cell Res; 1995 Nov; 221(1):160-71. PubMed ID: 7589241
    [Abstract] [Full Text] [Related]

  • 22. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
    Seth D, Shaw K, Jazayeri J, Leedman PJ.
    Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641
    [Abstract] [Full Text] [Related]

  • 23. Epidermal growth factor-induced activation of the insulin-like growth factor I receptor in rat hepatocytes.
    Hallak H, Moehren G, Tang J, Kaou M, Addas M, Hoek JB, Rubin R.
    Hepatology; 2002 Dec; 36(6):1509-18. PubMed ID: 12447877
    [Abstract] [Full Text] [Related]

  • 24. Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines.
    Chow L, Rezmann L, Imamura K, Wang L, Catt K, Tikellis C, Louis WJ, Frauman AG, Louis SN.
    Prostate; 2008 May 01; 68(6):651-60. PubMed ID: 18288685
    [Abstract] [Full Text] [Related]

  • 25. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
    Lee YF, Lin WJ, Huang J, Messing EM, Chan FL, Wilding G, Chang C.
    Cancer Res; 2002 Nov 01; 62(21):6039-44. PubMed ID: 12414626
    [Abstract] [Full Text] [Related]

  • 26. Modulation of the steroidogenic activity of luteinizing hormone by insulin and insulin-like growth factor-I through interaction with the cAMP-dependent protein kinase signaling pathway in the trout ovary.
    Méndez E, Montserrat N, Planas JV.
    Mol Cell Endocrinol; 2005 Jan 14; 229(1-2):49-56. PubMed ID: 15607528
    [Abstract] [Full Text] [Related]

  • 27. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
    Lowe WL, Fu R, Banko M.
    Endocrinology; 1997 Jun 14; 138(6):2219-26. PubMed ID: 9165004
    [Abstract] [Full Text] [Related]

  • 28. Growth factor/growth factor receptor loops in autocrine growth regulation of human prostate cancer DU145 cells.
    Ligęza J, Ligęza J, Klein A.
    Acta Biochim Pol; 2011 Jun 14; 58(3):391-6. PubMed ID: 21887406
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
    Lipson KE, Pang L, Huber LJ, Chen H, Tsai JM, Hirth P, Gazit A, Levitzki A, McMahon G.
    J Pharmacol Exp Ther; 1998 May 14; 285(2):844-52. PubMed ID: 9580635
    [Abstract] [Full Text] [Related]

  • 30. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG, Dilts CA, Dziubinski ML, Pierce LJ, Ethier SP.
    Mol Carcinog; 1996 Mar 14; 15(3):227-38. PubMed ID: 8597535
    [Abstract] [Full Text] [Related]

  • 31. EGF-dependent and independent programmed cell death pathways in NCI-H596 nonsmall cell lung cancer cells.
    Lei W, Mayotte JE, Levitt ML.
    Biochem Biophys Res Commun; 1998 Apr 28; 245(3):939-45. PubMed ID: 9588219
    [Abstract] [Full Text] [Related]

  • 32. Parallel contractile signal transduction pathways activated by receptors for thrombin and epidermal growth factor-urogastrone in guinea pig gastric smooth muscle: blockade by inhibitors of mitogen-activated protein kinase-kinase and phosphatidyl inositol 3'-kinase.
    Zheng XL, Renaux B, Hollenberg MD.
    J Pharmacol Exp Ther; 1998 Apr 28; 285(1):325-34. PubMed ID: 9536028
    [Abstract] [Full Text] [Related]

  • 33. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y, Shi C, Inge L, Hibner M, Balducci J, Huang Y.
    Oncogene; 2010 Sep 02; 29(35):4947-58. PubMed ID: 20562913
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
    Reddy KB, Mangold GL, Tandon AK, Yoneda T, Mundy GR, Zilberstein A, Osborne CK.
    Cancer Res; 1992 Jul 01; 52(13):3636-41. PubMed ID: 1617636
    [Abstract] [Full Text] [Related]

  • 35. Epidermal growth factor regulates protein kinase A activity in murine fibrosarcoma cells: differences between metastatic and nonmetastatic tumor cell variants.
    Fishman D, Galitzki L, Priel E, Segal S.
    Cancer Res; 1997 Dec 01; 57(23):5410-5. PubMed ID: 9393768
    [Abstract] [Full Text] [Related]

  • 36. Cross-talk between angiotensin II receptors and the tyrosine kinases and phosphatases.
    Inagami T, Eguchi S, Numaguchi K, Motley ED, Tang H, Matsumoto T, Yamakawa T.
    J Am Soc Nephrol; 1999 Jan 01; 10 Suppl 11():S57-61. PubMed ID: 9892141
    [Abstract] [Full Text] [Related]

  • 37. Epidermal growth factor activates protein kinase C in the human endometrial cancer cell line HEC-1-A.
    Connor P, Talavera F, Kang JS, Burke J, Roberts J, Menon KM.
    Gynecol Oncol; 1997 Oct 01; 67(1):46-50. PubMed ID: 9345355
    [Abstract] [Full Text] [Related]

  • 38. The role of protein kinases A and C pathways in the regulation of mitogen-activated protein kinase activation in response to gonadotropin-releasing hormone receptor activation.
    Han XB, Conn PM.
    Endocrinology; 1999 May 01; 140(5):2241-51. PubMed ID: 10218977
    [Abstract] [Full Text] [Related]

  • 39. Alternate signaling pathways selectively regulate binding of insulin-like growth factor I and II on fetal rat bone cells.
    McCarthy TL, Ji C, Casinghino S, Centrella M.
    J Cell Biochem; 1998 Mar 15; 68(4):446-56. PubMed ID: 9493908
    [Abstract] [Full Text] [Related]

  • 40. CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell line.
    Wendtner CM, Schmitt B, Gruss HJ, Druker BJ, Emmerich B, Goodwin RG, Hallek M.
    Cancer Res; 1995 Sep 15; 55(18):4157-61. PubMed ID: 7545087
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.